Open AccessAntimicrobial Activity of Ceftazidime-Avibactam Against Contemporary Pathogens From Urinary Tract Infections and Intra-abdominal Infections Collected From US Children During the 2016–2019 INFORM Surveillance Program
Author(s) -
Lynn-Yao Lin,
Todd Riccobene,
Dmitri Debabov
Publication year - 2020
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000003035
Subject(s) - ceftazidime/avibactam , enterobacter cloacae , klebsiella pneumoniae , microbiology and biotechnology , medicine , ceftazidime , pseudomonas aeruginosa , proteus mirabilis , broth microdilution , antimicrobial , urinary system , escherichia coli , minimum inhibitory concentration , biology , bacteria , genetics , biochemistry , gene
Antibacterial activity of ceftazidime-avibactam (CAZ-AVI) was evaluated against bacterial isolates from children in the United States with a urinary tract infection (UTI) or intra-abdominal infection (IAI) during the 2016-2019 International Network for Optimal Resistance Monitoring program. Prevalence of isolates and susceptibility to CAZ-AVI in pediatric and adult patients were compared.